Journal of visualized experiments : JoVE · 2026
A Microcarrier Bead-Based Three-Dimensional Angiogenesis Model Using Human Umbilical Vein Endothelial Cells.
СтатьяVideo-Audio MediaПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lin Jian, Zhu Ying, Chen Yin, Zhou Xingkai, Ye Ting, Wu Yibo, Wu Shuang, Yang Shu, He Yang, Li Yongsheng
Аннотация
Angiogenesis is a multistep biological process involving endothelial cell activation, migration, elongation, lumen formation, branching, and anastomosis. Conventional two-dimensional culture systems are useful for the preliminary evaluation of drugs, genes, or culture conditions, but they do not adequately recapitulate the spatial organization of endothelial morphogenesis within a three-dimensional extracellular matrix. The present protocol describes a microcarrier bead-based three-dimensional angiogenesis assay using human umbilical vein endothelial cells (HUVECs). The HUVECs are first seeded onto microcarrier beads bearing chemically coupled acid-denatured porcine type I collagen and then embedded in a basement membrane matrix. Oral mucosal fibroblasts are subsequently seeded on top of the gel to provide paracrine support for endothelial sprouting and vascular-like structure formation. The culture medium is replaced every 2 days, and sprouting behavior and angiogenic phenotypes are monitored by inverted microscopy. Under appropriate culture conditions, endothelial sprouts emerge within several days, followed by the formation of lumen-like structures and inter-sprout connections. This method provides a convenient and reproducible platform for in vitro studies of endothelial morphogenesis and can be further applied to investigations of gene manipulation, pharmacological intervention, and disease modeling.